The Journal of Experimental Medicine
ELISpot, FluoroSpot and ELISA kits from Mabtech
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 315K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ivanova, S.
Right arrow Articles by Tracey, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ivanova, S.
Right arrow Articles by Tracey, K. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/7/327/ $5.00
The Journal of Experimental Medicine, Volume 188, Number 2, July 20, 1998 327-340


Articles

Cerebral Ischemia Enhances Polyamine Oxidation: Identification of Enzymatically Formed 3-Aminopropanal as an Endogenous Mediator of Neuronal and Glial Cell Death

Svetlana Ivanova*,**, Galina I. Botchkina*, Yousef Al-Abed||,||, Malcolm Meistrell, III*, Franak Batliwalla{dagger}{dagger}, Janet M. Dubinsky{ddagger}, Constantino Iadecola§, Haichao Wang*,§§, Peter K. Gregersen{dagger}{dagger}, John W. Eaton||, and Kevin J. Tracey*

From the * Laboratory of Biomedical Science, The Picower Institute for Medical Research, Manhasset, New York 11030; the {ddagger} Department of Physiology and the § Department of Neurology, University of Minnesota, Minneapolis, Minnesota 55455; the || Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030; the Department of Surgery, North Shore University Hospital–New York University Medical School, Manhasset, New York 11030; the ** Department of Experimental Pathology and Laboratory Medicine, Albany Medical College, Albany, New York 12208; and the {dagger}{dagger} Division of Biology and Human Genetics, Department of Medicine, and the §§ Department of Emergency Medicine, North Shore University Hospital–New York University Medical School, Manhasset, New York 11030; and the ||||Laboratory of Organic Chemistry, The Picower Institute for Medical Research, Manhasset, New York 11030

To elucidate endogenous mechanisms underlying cerebral damage during ischemia, brain polyamine oxidase activity was measured in rats subjected to permanent occlusion of the middle cerebral artery. Brain polyamine oxidase activity was increased significantly within 2 h after the onset of ischemia in brain homogenates (15.8 ± 0.9 nmol/h/mg protein) as compared with homogenates prepared from the normally perfused contralateral side (7.4 ± 0.5 nmol/h/mg protein) (P <0.05). The major catabolic products of polyamine oxidase are putrescine and 3-aminopropanal. Although 3-aminopropanal is a potent cytotoxin, essential information was previously lacking on whether 3-aminopropanal is produced during cerebral ischemia. We now report that 3-aminopropanal accumulates in the ischemic brain within 2 h after permanent forebrain ischemia in rats. Cytotoxic levels of 3-aminopropanal are achieved before the onset of significant cerebral cell damage, and increase in a time-dependent manner with spreading neuronal and glial cell death. Glial cell cultures exposed to 3-aminopropanal undergo apoptosis (LD50 = 160 µM), whereas neurons are killed by necrotic mechanisms (LD50 = 90 µM). The tetrapeptide caspase 1 inhibitor (Ac-YVAD-CMK) prevents 3-aminopropanal–mediated apoptosis in glial cells. Finally, treatment of rats with two structurally distinct inhibitors of polyamine oxidase (aminoguanidine and chloroquine) attenuates brain polyamine oxidase activity, prevents the production of 3-aminopropanal, and significantly protects against the development of ischemic brain damage in vivo. Considered together, these results indicate that polyamine oxidase–derived 3-aminopropanal is a mediator of the brain damaging sequelae of cerebral ischemia, which can be therapeutically modulated.

Key Words: stroke • infarction • spermine • apoptosis • caspase


Address correspondence to Kevin J. Tracey, The Picower Institute for Medical Research, 350 Community Dr., Manhasset, NY 11030. Phone: 516-562-9476; Fax: 516-562-2356; E-mail: ktracey{at}picower.edu

Abbreviations used: EIMS, Electrospray ionization mass spectroscopy; iNOS, inducible nitric oxide synthase; NMDA, N-methyl-D-aspartate; NMR, nuclear magnetic resonance; PAO, polyamine oxidase; PCA, perchloric acid; TTC, 2,3,5-triphenyltetrazolium chloride; TUNEL, Tdt-mediated dUTP–biotin nick-end labeling.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS